Frewitt

Partner Content

Small molecule API: Shining a spotlight on new innovations in milling

Specialist small molecule API services are rising in demand as global appetite for novel therapies and treatments grow. This is putting third-party pharmaceutical mill providers and their capabilities in the spotlight.

Fi Forrest

Partner Content

Cannabidiol milling: Selecting the right equipment for CBD testing

Partner Content

Accurate dosing: How to achieve maximum precision with poor-flowing products

Partner Content

Nanomilling: How the latest Dynamic Light Scattering (DLS) technology could revolutionise hydrophobic API production

Partner Content

Reinventing the drum: How milling innovations are cutting costs and reducing footprints

Partner Content

Flexible grinding processes for sterile nanopharmaceutical manufacturing

Partner Content

Pharmaceutical processing: Why the industry is turning to turnkey

Partner Content

API landscape in 2022: Drivers and solutions for small molecules

Partner Content

Solving pharma’s process development challenges one API at a time

Miranda McLaren

Partner Content

From operator to API: how the future of micronisation means no more compromise

Partner Content

Meet the Swiss company creating a new gold standard in micronisation and user safety

Partner Content

Turnkey pharma projects: Why working with a process-driven solutions provider is the key to success

Partner Content

How one company is embracing collaboration to advance pharmaceutical technology

Partner Content

Down to the nanometre: Submicron particle size reduction and the NanoWitt bead mill

Partner Content

The Smallest of Particles Offer the Biggest Challenges

Partner Content

Small molecule API: Shining a spotlight on new innovations in milling

Cannabidiol milling: Selecting the right equipment for CBD testing

Accurate dosing: How to achieve maximum precision with poor-flowing products

Nanomilling: How the latest Dynamic Light Scattering (DLS) technology could revolutionise hydrophobic API production

Reinventing the drum: How milling innovations are cutting costs and reducing footprints

Flexible grinding processes for sterile nanopharmaceutical manufacturing

Pharmaceutical processing: Why the industry is turning to turnkey

API landscape in 2022: Drivers and solutions for small molecules

Development and Manufacturing of Primary Packaging and Medical Devices

ORPHELIA Pharma chooses Tanner Pharma to distribute Kimozo

Solving pharma’s process development challenges one API at a time

From operator to API: how the future of micronisation means no more compromise

Meet the Swiss company creating a new gold standard in micronisation and user safety

Turnkey pharma projects: Why working with a process-driven solutions provider is the key to success

How one company is embracing collaboration to advance pharmaceutical technology

Down to the nanometre: Submicron particle size reduction and the NanoWitt bead mill

The Smallest of Particles Offer the Biggest Challenges

Frewitt’s Technical Center and process consultancy

Development and Manufacturing of Primary Packaging and Medical Devices

ORPHELIA Pharma chooses Tanner Pharma to distribute Kimozo

Subscribe to our Newsletter